Aktie A1CZAA ENDYMED LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Endymed Ltd TEL AVIV STOCK EXCHANGE

Aktien

A1CZAA

IL0011010217

ENDY

Verzögert TEL AVIV STOCK EXCHANGE
Andere Börsenplätze
 13:24:09 25.04.2024 		% 5 Tage % 1. Jan.
325 ILa +0,12 % Intraday Chart für Endymed Ltd +0,03 % +12,46 %
20.03. Endymed Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Endymed Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Endymed Ltd Receives FDA Approval for Marketing and Sales of its Brand-New Laser Based Hair Removal Device
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Endymed Ltd Appoints Bill Scott as US Subsidiary President, Endymed Inc
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Endymed Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
Endymed Medical Ltd. announced that it has received $7 million in funding from OHMK Medical Technology Co. Ltd.
Endymed Medical Ltd. announced that it expects to receive $7 million in funding from OHMK Medical Technology Co. Ltd.
Endymed Ltd. Obtains FDA's First Approval of a RF Device for Home Treatment for Wrinkle Reduction
Endymed Medical Ltd. acquired Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. ENDY Aktie
  4. A1CZAA Aktie
  5. Nachrichten Endymed Ltd
  6. Andere Sprachen